Preclinical and Clinical Insights into Nano Targeted Cardio Nutraceuticals

Abstract

The development of nano-targeted cardio nutraceuticals establishes an advanced intersection between nanotechnology and nutraceutical science which scientists use to prevent and treat cardiovascular diseases. The chapter presents complete details about both preclinical research and clinical studies which demonstrate how scientists create and improve and test the medical value of nano-enabled nutraceutical systems. The study focuses on how advanced nanocarriers help bioactive phytoconstituents like polyphenols and flavonoids and essential fatty acids to achieve better solubility and stability and bioavailability and targeted delivery. Preclinical studies show distinct enhancements in anti-inflammatory and antioxidant and lipid-lowering and endothelial-protective effects while early clinical results indicate that patients stay more compliant with their treatment while experiencing fewer side effects when compared to standard treatments. The chapter addresses major obstacles that scientists face which include challenges in scaling up their work and meeting regulatory requirements and ensuring long-term safety and establishing solid clinical proof. Scientists believe that nano-targeted cardio nutraceuticals will revolutionize cardiovascular treatment by providing patients with precise and effective and personalized therapeutic solutions.